Heart Failure Treatment With Ventura Device Study
Part of Heart & circulation, Hormones & metabolism clinical trials.
This study tests a new heart implant called the Ventura IASD in people with weakened heart pumping (low ejection fraction). The goal is to see if it helps relieve symptoms and improve quality of life in patients with chronic heart failure.
Summary written for real people, not researchers, by Clin2.
Who can take part
- Weakened heart with ejection fraction of 40% or less (your heart isn't pumping enough blood)
- Moderate heart failure symptoms (Class III: difficulty with everyday activities) that have lasted at least 6 months
- On stable heart failure medications for at least 3 months
- Blood test showing elevated heart failure marker (NTproBNP ≥ 1,200)
- Age 18 or older and able to attend all follow-up visits
- Able to undergo MRI scans and willing to sign consent form
Quick eligibility check
Answer a few plain-language questions, based on this study's own requirements, to get a preliminary sense of fit.
Similar studies
Other trials that look related to this one.
This study tests whether a new drug called AC01 can help people with advanced heart failure (where the heart doesn't pump well) feel better and stay healthier. You'll be randomly assigned to receive either AC01 or placebo, and researchers will monitor your heart health closely throughout the study.
This trial studies whether the ContraBand device can be safely placed in people with long-term, symptomatic heart failure and reduced heart pumping. It also looks at whether the approach is practical and tolerable, and gathers early safety information.
This trial tests a new device called the VentriCure that helps the heart pump blood. It is for people with severe coronary artery disease and a weak heart who cannot have bypass surgery or choose not to.
This trial is testing a new way to use MRI scans to help people with heart failure who need a special pacemaker called a CRT device. It may help doctors better understand how to treat your heart condition.
This study tests whether using two implanted devices (CardioMems and BaroStim) can improve heart function and symptoms in people with advanced heart failure. It aims to help patients who are already on standard medications get even better results.
This trial studies a heart pacing approach in people with heart failure symptoms despite preserved heart pumping. It aims to see whether changing heart timing can improve how you feel and how your heart works during exercise.
Hear when a new Heart Failure With Reduced Ejection Fraction (HFrEF) trial opens
We’ll email you when one opens — at most once a week, no account needed, unsubscribe anytime.